EPHA2 and pancreatic neoplasm: These nanoparticles selectivelybind to captured EVs on a sensor chip, generating a localized plasmoniceffect that enhances detection sensitivity and specificity (Figure B). A major application of nPES is the detectionof EphA2-positive EVs, a biomarker linked to pancreatic cancer.